Cronos Group Inc. (NASDAQ:CRON ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Anna Shlimak - Chief Financial Officer Harrison Aaron - Corporate Participant Michael Ryan Gorenstein - President, CEO & Chairman Operator Good morning. My name is Stephen, and I will be your conference operator today.

Net revenue in Q2 2025 increased by 21% year-over-year PEACE NATURALS ® retained its position as the number one cannabis brand in Israel 1 Highest-ever international and Israel revenue, fueled by strong global demand Industry-leading balance sheet with $834 million in total cash and cash equivalents and short-term investments TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2025 second quarter business results. "Cronos delivered another quarter of strong performance, highlighted by record sales from Cronos Israel and continued momentum in international markets.

Canadian cannabis stocks are gaining momentum this week as the U.S. cannabis market continues to expand. Legal sales in the U.S. are projected to reach nearly $45 billion in 2025. Economic impact is expected to grow even larger, fueling jobs and tax revenue. Currently, adult-use cannabis is legal in over 20 states, while medical programs operate in many more. Recent headlines show renewed interest in federal reform. Lawmakers are once again pushing for rescheduling and broader legalization. In the meantime, local regulatory issues remain in the spotlight. Some U.S. states are revising licensing rules, which adds pressure on retail operators. Despite the challenges, optimism is building among investors. Canadian firms with U.S. exposure may benefit from these developments. Therefore, traders are closely watching for technical breakouts and industry catalysts.